Original Research

A combined analysis of four observational studies evaluating the intraocular pressure-lowering ability and tolerability of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension

Stevens A, Iliev ME, de Jong L, Grobeiu I, Hommer A

Clinical Ophthalmology 2016, 10:635-641

Published Date: 6 April 2016